Transforming growth factor B

From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history

Transforming Growth Factor B or TGFB.[1]

Function[edit | edit source]

[1][2]

ME/CFS[edit | edit source]

Notable studies[edit | edit source]

  • 2022, Circadian rhythm disruption in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Implications for the post-acute sequelae of COVID-19[2] - (Full text)

See also[edit | edit source]

Learn more[edit | edit source]

References[edit | edit source]

  1. ↑ 1.0 1.1 "TGFB - Genes". Gene cards. Retrieved April 1, 2022.
  2. ↑ 2.0 2.1 McCarthy, Michael J. (March 1, 2022). "Circadian rhythm disruption in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Implications for the post-acute sequelae of COVID-19". Brain, Behavior, & Immunity - Health. 20 (5): 100412. doi:10.1016/j.bbih.2022.100412. ISSN 2666-3546.

circadian rhythm Physical, mental, and behavioral changes that follow a 24-hour cycle, responding mostly to light and dark. Controlled the brain's hypothalamus. (Learn more: www.nigms.nih.gov)

myalgic encephalomyelitis (M.E.) - A disease often marked by neurological symptoms, but fatigue is sometimes a symptom as well. Some diagnostic criteria distinguish it from chronic fatigue syndrome, while other diagnostic criteria consider it to be a synonym for chronic fatigue syndrome. A defining characteristic of ME is post-exertional malaise (PEM), or post-exertional neuroimmune exhaustion (PENE), which is a notable exacerbation of symptoms brought on by small exertions. PEM can last for days or weeks. Symptoms can include cognitive impairments, muscle pain (myalgia), trouble remaining upright (orthostatic intolerance), sleep abnormalities, and gastro-intestinal impairments, among others. An estimated 25% of those suffering from ME are housebound or bedbound. The World Health Organization (WHO) classifies ME as a neurological disease.

Retrieved from "https://me-pedia.org/w/index.php?title=Transforming_growth_factor_B&oldid=238993"